Immunization in multiple sclerosis and other childhood immune-mediated disorders of the central nervous system: A review of the literature

2021 ◽  
Author(s):  
Ismail Solmaz ◽  
Banu Anlar
Keyword(s):  
Multiple Sclerosis ◽  
Central Nervous System ◽  
Nervous System ◽  
Review Of The Literature ◽  
System A ◽  
Immune Mediated ◽  
The Central Nervous System

Immune and Infectious Diseases

2018 ◽  
pp. 430-470
Author(s):  
Andrea C. Adams
Keyword(s):  
Multiple Sclerosis ◽  
Central Nervous System ◽  
Nervous System ◽  
Young People ◽  
Connective Tissue ◽  
Infectious Diseases ◽  
Temporal Profile ◽  
Immune Mediated ◽  
The Central Nervous System ◽  
The Common

Many immune-mediated diseases and infections affect the central and peripheral nervous systems. The common feature that characterizes both immune-mediated diseases and infections is a subacute temporal profile. Immune-mediated disease can affect only the nervous system or involve the nervous system as part of a systemic illness, as in vasculitis and connective tissue disease. Multiple sclerosis (MS), the most common disabling neurologic illness of young people, is the prototypical immune-mediated disease of the central nervous system (CNS).

Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: a novel gene therapy approach

2000 ◽  
Vol 107 (2) ◽  
pp. 184-190 ◽  
Author(s):  
Gianvito Martino ◽  
Pietro L Poliani ◽  
Roberto Furlan ◽  
Peggy Marconi ◽  
Joseph C Glorioso ◽  
...  
Keyword(s):  
Gene Therapy ◽  
Central Nervous System ◽  
Nervous System ◽  
Demyelinating Diseases ◽  
Cytokine Therapy ◽  
Therapy Approach ◽  
Gene Therapy Approach ◽  
System A ◽  
Immune Mediated ◽  
The Central Nervous System

scholarly journals Original article Primary angiitis of the central nervous system: a study of histopathological patterns and review of the literature

2014 ◽  
Vol 2 ◽  
pp. 187-196 ◽  
Author(s):  
Vaishali Suri ◽  
Aanchal Kakkar ◽  
Mehar C. Sharma ◽  
Madakasira V. Padma ◽  
Ajay Garg ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Review Of The Literature ◽  
System A ◽  
Primary Angiitis ◽  
The Central Nervous System

scholarly journals Traditional Uses of Cannabinoids and New Perspectives in the Treatment of Multiple Sclerosis

Medicines ◽  
2018 ◽  
Vol 5 (3) ◽  
pp. 91 ◽  
Author(s):  
Francesca Gado ◽  
Maria Digiacomo ◽  
Marco Macchia ◽  
Simone Bertini ◽  
Clementina Manera
Keyword(s):  
Multiple Sclerosis ◽  
Central Nervous System ◽  
Nervous System ◽  
Disease Progression ◽  
Endocannabinoid System ◽  
Neuroprotective Effects ◽  
Demyelinating Disorder ◽  
Immune Mediated ◽  
The Central Nervous System

Recent findings highlight the emerging role of the endocannabinoid system in the control of symptoms and disease progression in multiple sclerosis (MS). MS is a chronic, immune-mediated, demyelinating disorder of the central nervous system with no cure so far. It is widely reported in the literature that cannabinoids might be used to control MS symptoms and that they also might exert neuroprotective effects and slow down disease progression. This review aims to give an overview of the principal cannabinoids (synthetic and endogenous) used for the symptomatic amelioration of MS and their beneficial outcomes, providing new potentially possible perspectives for the treatment of this disease.

Sign in / Sign up

Export Citation Format

Share Document